stockrow
Friday 6 November 2026
Export YI’s income statement to Excel — free account
111, Inc. Sponsored ADR
YI Healthcare Medical Distribution
111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024.
- Revenue
- −29.6%
- EPS
- −113.7%
- Free cash flow
- −185.7%
- Total debt
- +82.5%
Quarter to March 2026, against a year earlier
2.91
0.07
−2.35%
Follow YI
Alert me
111, Inc. Sponsored ADR (YI) P/E ratio
111, Inc. Sponsored ADR has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| Jun 2025 | 0.0× | — |
| 26 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ACH Accendra Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| MEDS DataMeds AI, Inc compare | n/m |
| YI 111, Inc. Sponsored ADR | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| SNYRQ Synergy CHC Corp. compare | n/m |
| COSM Cosmos Health Inc. compare | n/m |
| HSIC Henry Schein, Inc. compare | 22.8× |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)